Quick10K

⚲

Cell Medx

Filings

S-1	2021-03-04	Public Filing
10-Q	2021-02-28	Filed 2021-04-09
10-Q	2020-11-30	Filed 2021-01-14
10-Q	2020-08-31	Filed 2020-10-15
10-K	2020-05-31	Filed 2020-09-15
10-Q	2020-02-29	Filed 2020-04-14
10-Q	2019-11-30	Filed 2020-01-14
10-Q	2019-08-31	Filed 2019-10-15
10-K	2019-05-31	Filed 2019-09-06
10-Q	2019-02-28	Filed 2019-04-22
10-Q	2018-11-30	Filed 2019-01-14
10-Q	2018-08-31	Filed 2018-10-15
10-K	2018-05-31	Filed 2018-09-13
10-Q	2018-02-28	Filed 2018-04-16
10-Q	2017-11-30	Filed 2018-01-16
10-Q	2017-08-31	Filed 2017-10-17
10-K	2017-05-31	Filed 2017-08-29
10-Q	2017-02-28	Filed 2017-04-14
10-Q	2016-11-30	Filed 2017-01-17
10-Q	2016-08-31	Filed 2016-10-17
10-K	2016-05-31	Filed 2016-09-13
10-Q	2016-02-29	Filed 2016-04-14
10-Q	2015-11-30	Filed 2016-01-14
10-Q	2015-08-31	Filed 2015-10-15
10-K	2015-05-31	Filed 2015-09-03
10-Q	2015-02-28	Filed 2015-04-14
10-Q	2014-11-30	Filed 2015-01-14
10-Q	2014-08-31	Filed 2014-10-09
10-K	2014-05-31	Filed 2014-08-26
10-Q	2014-02-28	Filed 2014-04-18
10-Q	2013-11-30	Filed 2014-01-13
10-Q	2013-08-31	Filed 2013-10-03
10-Q	2013-02-28	Filed 2013-04-15
10-Q	2012-11-30	Filed 2013-01-16
10-Q	2012-08-31	Filed 2012-10-15
10-K	2012-05-31	Filed 2012-10-11
10-Q	2012-02-29	Filed 2012-04-09
10-Q	2011-11-30	Filed 2012-03-02
10-Q	2011-08-31	Filed 2011-10-17
10-K	2011-05-31	Filed 2011-09-21

Reports

8-K	2020-07-30
8-K	2020-06-08
8-K	2020-05-06
8-K	2020-01-29
8-K	2019-06-24
8-K	2019-03-21
8-K	2018-12-27
8-K	2018-05-07
8-K	2018-03-23

Cell Medx Financials

CMXC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Cash	0	0	30	24	24	19	13	11	5	2	1	1	0	0	29	1	7	2	15	28	38	118	9	67	326	108	24	8	24	131	57
Accounts Receivable
Inventory															1	1	1	1	1	5	1	4	3	8	22	29	30	11	60	64	73
PP&E																28	26	35	32	207	207	207	256	194	154	116	79		2	1	1
Assets	0	0	30	24	24	19	13	11	5	2				105	59	47	45	48	167	269	252	379	335	294	532	376	163	45	95	222	191
Accounts Payable						0	0		0	0	0	2	40	159	186	220	256	302	326	384	404	397	453	448	486	515	544	595	669	706	734
Long-Term Debt
Liabilities	7	13	17	13	13	13	13	13	13	13				393	580	731	943	1,115	1,367	1,681	1,895	880	1,107	1,463	1,563	982	1,001	1,119	1,532	1,860	1,963
Stockholders' Equity	-7	-13	13	11	11	6	-0	-2	-8	-11	-15	-20	-68	-288	-521	-684	-899	-1,067	-1,201	-1,413	-1,642	-502	-772	-1,169	-1,031	-605	-839	-1,073	-1,437	-1,638


Income Statement ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Revenue	0	0	0	0	0	0	0	0	0	0	0	0			5								1	0
Cost of Revenue															-2								0	0
Gross Profit															3	13	1	1	1	5	2	0	0	0
R&D															146	32	554	25	16	56	73	67	53	104	48	41	111	218	34	64	15
SG&A	0	5	3	1	0	5	6	2	6	3	4	5	48		70	52	73	59	42	68	44	51	121	183	54	34	80	67	24	36	57
Tax
Net Income	-4	-6	-4	-2	0	-1	-6	-2	-6	-2	-4	-5	-48	-273	-419	-292	-1,029	-480	-296	-334	-279	-1,060	-305	394	-833	-181	-296	-236	-128	-391	-144


Cash Flow ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating	-2	-9	0	-7	0	-5	-6	-2	-6	-3	-1	0	-1	-20	-203	-92	-98	-65	-175	-84	-123	-280	-157	-194	-108	-225	-85	-31		-142
Cash Investing	0	0	0	0	0	0	0	0	0	0	0	0			86	-9	-19	-14	-1	-185	-15	0	-95	0						0	0
Cash Financing	2	9	30	1	0	0	0	0	0	0	0	0			145	75	122	74	186	285	149	360	142	254	366	6	0	16		250	33